Flavonoid apigenin is an inhibitor of the NAD+ase CD38: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome (Diabetes (2013) 62 (1084-1093))

Carlos Escande, Veronica Nin, Nathan L. Price, Verena Capellini, Ana P. Gomes, Maria Thereza Barbosa, Luke O'Neil, Thomas A. White, David A. Sinclair, Eduardo N. Chini

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)1428
Number of pages1
Issue number4
StatePublished - Apr 2014
Externally publishedYes

Cite this